The meeting was very productive, eventful, and informative. The company guided the “ASTOM” representatives through the complete technological chain of production — from the beginning of the assembly of products on a modern robotic line to the release of products in finished packaging.
Since the beginning of 2022, Gemamed, a resident company of the Technopolis Moscow Special Economic Zone (SEZ), has supplied more than 810,000 medical devices for ostomy patients, who receive these goods from the city free of charge, as part of an offset agreement. This was reported by the press service of the Complex for Economic Policy and Property and Land Relations of the capital.
GemaTech took part in the RIA Novosti special project on public-private partnership in the Offset Agreement section.
The journal “ASTOM: Guide to Active Life” published an article on GemaTech, a company involved in the production of stoma care products.
Sergey Sobyanin held a meeting with representatives of major pharmaceutical companies where they discussed the development of the industry and import substitution in conditions of external sanctions pressure.
The government has approved the rules for the import into and export from the Russian Federation of biomaterials obtained during clinical trials of medicines for human use. They will come into force on September 1 and will be valid until September 1, 2028; a corresponding decree of the Russian government has been published on the official Internet portal of legal information.
We use cookies to analyze events on our website, which allows us to improve the site's performance. If you do not want your data to be processed, please disable cookies in your browser settings. By continuing to use our site, you accept its terms of use and give your consent to the processing of cookies. For more detailed information on the use of cookies and how to opt out, please refer to our Cookie Policy.